- A June 29 article on Rhone-Poulenc Rorer's Taxotere should havesaid that the semisynthetic compound is derived from the needles of theEuropean yew tree.- A June 30 article on The Liposome Co.'s amphotericin B LipidComplex should have said the company plans to file a new drugapplication with the FDA at the end of 1995 or in early 1996. AlsoLiposome's common stock (NASDAQ:LIPO) closed Thursday at$5.75, up 50 cents.- The July 1 issue included an incorrect spelling of Rep. John Dingell'sname.

(c) 1997 American Health Consultants. All rights reserved.

No Comments